Please use this identifier to cite or link to this item:
|Title:||Nephrotoxicity of Cyclosporine: The Role of Platelet-Activating Factor and Thromboxane|
|Authors:||Santos, Oscar Fernando Pavão dos [UNIFESP]|
Boim, Mirian Aparecida [UNIFESP]
Barros, Elvino José Guardão [UNIFESP]
Schor, Nestor [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
INST HENRI BEAUFOUR
|Publisher:||Amer Oil Chemists Soc|
|Citation:||Lipids. Champaign: Amer Oil Chemists Soc, v. 26, n. 12, p. 1320-1323, 1991.|
|Abstract:||Cyclosporine (CsA), an immunosuppressive agent, is potentially nephrotoxic. We had previously observed that acute administration of CsA to Munich-Wistar rats induced a decrease in single nephron glomerular filtration rate, due to a decline in glomerular plasma flow, and in the glomerular ultrafiltration coefficient. Moreover, these alterations were prevented when an antagonist of platelet-activating factor (PAF) was administered. In the present study we examined whether the protective effect of the PAF blocker in CsA nephrotoxicity could have been mediated by thromboxane (TxA2). Our data show that the PAF effects were not mediated by TxA2, since administration of dazmegrel, a thromboxane synthetase inhibitor, did not ameliorate the acute renal failure caused by CsA. Thus, PAF appears to be a direct mediator of acute CsA nephrotoxicity, while TxA2 is not significantly involved in this process.|
|Appears in Collections:||Artigo|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.